If you liked this article you might like

4 Biotech Names That Could Be M&A Targets
Takeda Acquires Ariad Pharmaceuticals in $5.2 Billion Deal
A Very Happy New Year for Investors in Japan
SEC Discloses Correspondence Over Valeant's Accounting Practices